Skip to main content

Long-term follow-up after transfer of care to adult healthcare in paediatric liver transplant recipients

In brief

Only 1 in 4 young liver transplant recipients met ideal outcome at 10 years

In this 60-person study, only 25% met the study's ideal-outcome criteria 10 years after transfer to adult care, although 93% were alive and 91% had a functioning graft. Medication non-adherence was documented in 20%, and broader non-adherence in 25%; these findings point to the need for individualized long-term follow-up, but do not establish which approaches will improve outcomes.

Journal
Journal of pediatric gastroenterology and nutrition (Q1)
Published
12 November 2026
Study design
Cohort / observational study
Evidence level
Level 3, Low (CEBM 3b)
Authors
Alberto Ferrarese, Mara Cananzi, Giacomo Germani, Annalisa Dolcet, Umberto Cillo, Claudia Mescoli, et al.
PMID
43016337
DOI
10.1002/jpn3.70617

Why clinicians should know about it

  • Picked for Pediatric Surgery (top studies of the week, 15 November 2026): Long-term outcomes and transition after paediatric liver transplantation

Abstract

OBJECTIVES: Paediatric liver transplantation (pLT) is associated with excellent long-term survival and quality of life. As a growing proportion of recipients survive into adulthood, long-term follow-up after transfer from paediatric to adult care is increasingly important. We aimed to describe patient and graft survival, retention in care, adherence, medical complications and achievement of an ideal outcome after transfer of care. METHODS: This prospective observational study included all pLT recipients who entered our centre's transition programme between January 2010 and December 2024. Prespecified outcomes included patient and graft survival, retention in adult care, attendance and medication adherence, a composite non-adherence outcome, post-transfer medical complications and the proportion achieving an ideal outcome at predefined timepoints. RESULTS: Sixty patients were included (53.3% male; median age at pLT 5 [2.1-10.4] years; median age at transfer of care 19.8 [interquartile range (IQR) 18.9-24] years). Patient survival at 1, 5, 10 and 15 years after transfer of care was 98%, 96%, 93% and 93%, while graft survival was 98%, 94%, 91% and 75%, respectively. At the time of transfer of care, 55% of patients fulfilled criteria for an ideal outcome; this decreased to 41.6% at 5 years and 25% at 10 years. Medication non-adherence was documented in 20%, and composite non-adherence in 25%. The tacrolimus Medication Level Variability Index was significantly associated with composite non-adherence (p = 0.007) and was higher in patients who developed chronic rejection than in those who did not (p = 0.05). CONCLUSIONS: Despite excellent long-term survival, pLT recipients reaching adulthood face increasing challenges over time, particularly regarding adherence. These descriptive findings support continued, individualised follow-up after transfer to adult healthcare.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.